CARIS LIFE SCIENCES, INC. for CARIS LIFE SCIENCES, INC.
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Medical/Disease Research/Clinical Labs MED
Reimbursement issues for lab-developed tests, self-referral legislation, FDA regulatory issues, health care reform, preventing co-payments for lab services, and accountable care organization, Sustainable Growth Rate reform, pathology reimbursement issues.
| Lobbyist | Covered position, as disclosed |
|---|---|
| AMY JENSEN CUNNIFFE | Asst. to Speaker of the House for Policy |
Health Issues HCR
Reimbursement issues for lab-developed tests, self-referral legislation, FDA regulatory issues, health care reform, preventing co-payments for lab services, and accountable care organizations, Sustainable Growth Rate reform, pathology reimbursement.
| Lobbyist | Covered position, as disclosed |
|---|---|
| AMY JENSEN CUNNIFFE | Asst. to the Speaker of the House for Policy |
Medicare/Medicaid MMM
Reimbursement issues for lab-developed tests, self-referral legislation, FDA regulatory issues, health care reform, preventing co-payments for lab services, and accountable care organizations, Sustainable Growth Rate reform, pathology reimbursement.
| Lobbyist | Covered position, as disclosed |
|---|---|
| AMY JENSEN CUNNIFFE | Asst. to the Speaker of the House for Policy |
Insurance INS
Reimbursement issues for lab-developed tests, self-referral legislation, FDA regulatory issues, health care reform, preventing co-payments for lab services, and accountable care organizations, Sustainable Growth Rate reform, pathology reimbursement.
| Lobbyist | Covered position, as disclosed |
|---|---|
| AMY JENSEN CUNNIFFE | Asst. to the Speaker of the House for Policy |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.